Hi-Tech Pharmacal Co., Inc. is a specialty manufacturer and marketer of prescription, over-the-counter and nutritional products. The Company develops, manufactures and markets products in three categories: generics, prescription brands and over-the-counter (OTC) brands. It produces a range of products for various disease states, including glaucoma, asthma, bronchial disorders, dermatological disorders, allergies, pain, stomach, oral care and other conditions. The Company's generic products are primarily prescription items and include oral solutions and suspensions, topical creams and ointments as well as nasal sprays. It also specializes in the manufacture of products in its sterile facility capable of producing liquid ophthalmic, otic and inhalation products. In April 2014, Akorn Inc acquired Hi-Tech Pharmacal Co., Inc.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry N/A
Sub-IndustryPharmaceuticals
SectorN/A
SymbolNASDAQ:HITK
CUSIP42840B10
Phone+1-516-7898228
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00
Hi-Tech Pharmacal (NASDAQ:HITK) Frequently Asked Questions
What is Hi-Tech Pharmacal's stock symbol?
Hi-Tech Pharmacal trades on the NASDAQ under the ticker symbol "HITK."
What is the consensus analysts' recommendation for Hi-Tech Pharmacal?
0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hi-Tech Pharmacal in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."
Has Hi-Tech Pharmacal been receiving favorable news coverage?
Headlines about HITK stock have been trending somewhat positive recently, Accern Sentiment reports. The research group scores the sentiment of press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Hi-Tech Pharmacal earned a daily sentiment score of 0.14 on Accern's scale. They also gave headlines about the healthcare company an impact score of 45.38 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.
How do I buy shares of Hi-Tech Pharmacal?
Shares of HITK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Hi-Tech Pharmacal?
Hi-Tech Pharmacal's mailing address is 369 Bayview Ave, AMITYVILLE, NY 11701-2801, United States. The healthcare company can be reached via phone at +1-516-7898228.
MarketBeat Community Rating for Hi-Tech Pharmacal (NASDAQ HITK)
MarketBeat's community ratings are surveys of what our community members think about Hi-Tech Pharmacal and other stocks. Vote "Outperform" if you believe HITK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HITK will underperform the S&P 500 over the long term. You may vote once every thirty days.
